A six-month, all-oral treatment regimen for multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) is not only more effective but also cost-saving compared to the longer therapies ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing ...

New Delhi: Nearly 20 months after a recommendation by the World Health Organization (WHO), India has finally begun to take steps for introducing an advanced, short-term treatment regimen to tackle ...

A new study identified that a semi-synthetic compound can be derived from natural compounds and shows potent activity against tuberculosis (TB), including multi-drug resistant TB. A new study ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A new study published in the American Society for Microbiology journal Microbiology Spectrum demonstrates that a novel semi-synthetic compound can be derived from natural compounds to produce potent ...

HAMBURG, GERMANY / ACCESS Newswire / April 30, 2026 / Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced that it has received two grants from the Gates Foundation for drug discovery ...